Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab

Fig. 2

CXCL10, CXCL11, IFNγ, IL-6, MCP2, and MCP3 time-dependent response curves. Dashed line (---) represents circulating levels of inflammatory proteins in healthy controls. Treatment cohorts are represented as PL (placebo), LY700mg (bamlanivimab 700 mg dose), LY2800mg (bamlanivimab 2800 mg dose) and LY7000mg (bamlanivimab 7000 mg dose) with corresponding colors

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us